JWCTF
Price
$0.66
Change
+$0.01 (+1.54%)
Updated
Aug 5 closing price
Capitalization
256.03M
SRZN
Price
$9.98
Change
+$0.42 (+4.39%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
81.86M
Interact to see
Advertisement

JWCTF vs SRZN

Header iconJWCTF vs SRZN Comparison
Open Charts JWCTF vs SRZNBanner chart's image
JW CAYMAN THERAPEUTICS
Price$0.66
Change+$0.01 (+1.54%)
Volume$688
Capitalization256.03M
Surrozen
Price$9.98
Change+$0.42 (+4.39%)
Volume$100
Capitalization81.86M
JWCTF vs SRZN Comparison Chart in %
Loading...
JWCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JWCTF vs. SRZN commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JWCTF is a Hold and SRZN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (JWCTF: $0.66 vs. SRZN: $9.56)
Brand notoriety: JWCTF and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JWCTF: 1% vs. SRZN: 64%
Market capitalization -- JWCTF: $256.03M vs. SRZN: $81.86M
JWCTF [@Biotechnology] is valued at $256.03M. SRZN’s [@Biotechnology] market capitalization is $81.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JWCTF’s FA Score shows that 1 FA rating(s) are green whileSRZN’s FA Score has 1 green FA rating(s).

  • JWCTF’s FA Score: 1 green, 4 red.
  • SRZN’s FA Score: 1 green, 4 red.
According to our system of comparison, both JWCTF and SRZN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JWCTF’s TA Score shows that 1 TA indicator(s) are bullish while SRZN’s TA Score has 6 bullish TA indicator(s).

  • JWCTF’s TA Score: 1 bullish, 1 bearish.
  • SRZN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SRZN is a better buy in the short-term than JWCTF.

Price Growth

JWCTF (@Biotechnology) experienced а +12.30% price change this week, while SRZN (@Biotechnology) price change was -13.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JWCTF($256M) has a higher market cap than SRZN($81.9M). JWCTF YTD gains are higher at: 307.531 vs. SRZN (-33.380).
JWCTFSRZNJWCTF / SRZN
Capitalization256M81.9M313%
EBITDAN/A-24.62M-
Gain YTD307.531-33.380-921%
P/E RatioN/AN/A-
RevenueN/A11.6M-
Total CashN/A102M-
Total DebtN/A7.97M-
TECHNICAL ANALYSIS
Technical Analysis
JWCTFSRZN
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bullish Trend 4 days ago
30%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
29%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
25%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
JWCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BEQAX35.940.34
+0.96%
American Century Equity Growth A
AFGZX32.070.04
+0.12%
Alger Global Equity Z
DNFGX43.73-0.07
-0.16%
Dunham Focused Large Cap Growth N
FKUQX25.23-0.14
-0.55%
Franklin Utilities A
BGAIX44.97-0.31
-0.68%
Baron Global Advantage Institutional

JWCTF and

Correlation & Price change

A.I.dvisor tells us that JWCTF and HSITF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JWCTF and HSITF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JWCTF
1D Price
Change %
JWCTF100%
N/A
HSITF - JWCTF
25%
Poorly correlated
N/A
CAPR - JWCTF
24%
Poorly correlated
+12.39%
SRRK - JWCTF
24%
Poorly correlated
+1.78%
INTS - JWCTF
23%
Poorly correlated
+7.10%
SRZN - JWCTF
15%
Poorly correlated
+5.87%
More

SRZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRZN has been loosely correlated with RNTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SRZN jumps, then RNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRZN
1D Price
Change %
SRZN100%
+5.87%
RNTX - SRZN
44%
Loosely correlated
N/A
INAB - SRZN
39%
Loosely correlated
+7.44%
IRON - SRZN
34%
Loosely correlated
+1.68%
KMSTF - SRZN
34%
Loosely correlated
N/A
ELDN - SRZN
32%
Poorly correlated
-1.09%
More